Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2022

Aug 5, 2022

60507_rns_2022-08-05_24ba7f2d-dc6d-4e34-94f3-75d2ece275e4.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [94 x 40] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

August 5, 2022

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1st Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation regarding loss of share certificates and issue of duplicate share certificates.

Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received below mentioned request for issue of duplicate Share Certificate(s) from the below Shareholder(s):

Sr.
No.
Name Folio No. Certificate
No.
Number
of Shares
Dist Nos.
From
Dist Nos.
To
Ms. T Alagammai P 0138608 370590 35 25330982 25331016

We shall issue the letter of confirmation(s) upon completion of necessary formalities by the shareholder(s).

Please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

==> picture [101 x 45] intentionally omitted <==

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in